Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation

2. Preface

3. Executive Summary

4. Impact of COVID-19 on Global Topical Pain Relief Market

5. Global Topical Pain Relief Market Outlook, 2016-2026F
5.1. Market Size & Analysis
5.1.1. Market Revenues
5.2. Market Share & Analysis
5.2.1. By Type
5.2.1.1. Prescription Pain Relief
5.2.1.2. Over-The-Counter Pain Relief
5.2.2. By Therapeutic Class
5.2.2.1. Non-Opioids
5.2.2.1.1. Nonsteroidal Anti-Inflammatory Drug
5.2.2.1.2. Methyl Salicylate
5.2.2.1.3. Capsaicin
5.2.2.1.4. Lidocaine
5.2.2.2. Opioids
5.2.2.2.1. Buprenorphine
5.2.2.2.2. Fentanyl
5.2.3. By Formulation
5.2.3.1. Cream
5.2.3.2. Gel
5.2.3.3. Spray
5.2.3.4. Patch
5.2.4. By Distribution Channel
5.2.4.1. Pharmacy Drug Store
5.2.4.2. E-Commerce
5.2.4.3. Others
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. South America
5.2.5.3. Europe
5.2.5.4. Middle East & Africa
5.2.5.5. Asia-Pacific
5.2.6. By Competitors
5.2.6.1. Competition Characteristics
5.2.6.2. Market Share & Analysis
5.2.6.3. Competitive Metrix

6. North America Topical Pain Relief Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.1.1. Market Revenues
6.2. Market Share & Analysis
6.2.1. By Type
6.2.2. By Therapeutic Class
6.2.3. By Formulation
6.2.4. By Distribution Channel
6.2.5. By Country
6.2.5.1. The US
6.2.5.2. Canada
6.2.5.3. Mexico
6.3. The US Topical Pain Relief Market Outlook, 2016-2026F
6.3.1. Market Size & Analysis
6.3.1.1. Market Revenues
6.3.2. Market Share & Analysis
6.3.2.1. By Type
6.3.2.2. By Therapeutic Class
6.3.2.3. By Formulation
6.3.2.4. By Distribution Channel
6.4. Canada Topical Pain Relief Market Outlook, 2016-2026F
6.4.1. Market Size & Analysis
6.4.1.1. Market Revenues
6.4.2. Market Share & Analysis
6.4.2.1. By Type
6.4.2.2. By Therapeutic Class
6.4.2.3. By Formulation
6.4.2.4. By Distribution Channel
6.5. Mexico Topical Pain Relief Market Outlook, 2016-2026F
6.5.1. Market Size & Analysis
6.5.1.1. Market Revenues
6.5.2. Market Share & Analysis
6.5.2.1. By Type
6.5.2.2. By Therapeutic Class
6.5.2.3. By Formulation
6.5.2.4. By Distribution Channel

7. South America Topical Pain Relief Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.1.1. Market Revenues
7.2. Market Share & Analysis
7.2.1. By Type
7.2.2. By Therapeutic Class
7.2.3. By Formulation
7.2.4. By Distribution Channel
7.2.5. By Country
7.2.5.1. Brazil
7.2.5.2. Others
7.3. Brazil Topical Pain Relief Market Outlook, 2016-2026F
7.3.1. Market Size & Analysis
7.3.1.1. Market Revenues
7.3.2. Market Share & Analysis
7.3.2.1. By Type
7.3.2.2. By Therapeutic Class
7.3.2.3. By Formulation
7.3.2.4. By Distribution Channel

8. Europe Topical Pain Relief Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.1.1. Market Revenues
8.2. Market Share & Analysis
8.2.1. By Type
8.2.2. By Therapeutic Class
8.2.3. By Formulation
8.2.4. By Distribution Channel
8.2.5. By Country
8.2.5.1. Germany
8.2.5.2. The UK
8.2.5.3. France
8.2.5.4. Italy
8.2.5.5. Spain
8.2.5.6. The Netherlands
8.2.5.7. Norway
8.2.5.8. Others
8.3. Germany Topical Pain Relief Market Outlook, 2016-2026F
8.3.1. Market Size & Analysis
8.3.1.1. Market Revenues
8.3.2. Market Share & Analysis
8.3.2.1. By Type
8.3.2.2. By Therapeutic Class
8.3.2.3. By Formulation
8.3.2.4. By Distribution Channel
8.4. The UK Topical Pain Relief Market Outlook, 2016-2026F
8.4.1. Market Size & Analysis
8.4.1.1. Market Revenues
8.4.2. Market Share & Analysis
8.4.2.1. By Type
8.4.2.2. By Therapeutic Class
8.4.2.3. By Formulation
8.4.2.4. By Distribution Channel
8.5. France Topical Pain Relief Market Outlook, 2016-2026F
8.5.1. Market Size & Analysis
8.5.1.1. Market Revenues
8.5.2. Market Share & Analysis
8.5.2.1. By Type
8.5.2.2. By Therapeutic Class
8.5.2.3. By Formulation
8.5.2.4. By Distribution Channel
8.6. Italy Topical Pain Relief Market Outlook, 2016-2026F
8.6.1. Market Size & Analysis
8.6.1.1. Market Revenues
8.6.2. Market Share & Analysis
8.6.2.1. By Type
8.6.2.2. By Therapeutic Class
8.6.2.3. By Formulation
8.6.2.4. By Distribution Channel
8.7. Spain Topical Pain Relief Market Outlook, 2016-2026F
8.7.1. Market Size & Analysis
8.7.1.1. Market Revenues
8.7.2. Market Share & Analysis
8.7.2.1. By Type
8.7.2.2. By Therapeutic Class
8.7.2.3. By Formulation
8.7.2.4. By Distribution Channel
8.8. The Netherlands Topical Pain Relief Market Outlook, 2016-2026F
8.8.1. Market Size & Analysis
8.8.1.1. Market Revenues
8.8.2. Market Share & Analysis
8.8.2.1. By Type
8.8.2.2. By Therapeutic Class
8.8.2.3. By Formulation
8.8.2.4. By Distribution Channel
8.9. Norway Topical Pain Relief Market Outlook, 2016-2026F
8.9.1. Market Size & Analysis
8.9.1.1. Market Revenues
8.9.2. Market Share & Analysis
8.9.2.1. By Type
8.9.2.2. By Therapeutic Class
8.9.2.3. By Formulation
8.9.2.4. By Distribution Channel

9. Middle East & Africa Topical Pain Relief Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. Market Revenues
9.2. Market Share & Analysis
9.2.1. By Type
9.2.2. By Therapeutic Class
9.2.3. By Formulation
9.2.4. By Distribution Channel
9.2.5. By Country
9.2.5.1. UAE
9.2.5.2. Saudi Arabia
9.2.5.3. South Africa
9.2.5.4. Turkey
9.2.5.5. Others
9.3. UAE Topical Pain Relief Market Outlook, 2016-2026F
9.3.1. Market Size & Analysis
9.3.1.1. Market Revenues
9.3.2. Market Share & Analysis
9.3.2.1. By Type
9.3.2.2. By Therapeutic Class
9.3.2.3. By Formulation
9.3.2.4. By Distribution Channel
9.4. Saudi Arabia Topical Pain Relief Market Outlook, 2016-2026F
9.4.1. Market Size & Analysis
9.4.1.1. Market Revenues
9.4.2. Market Share & Analysis
9.4.2.1. By Type
9.4.2.2. By Therapeutic Class
9.4.2.3. By Formulation
9.4.2.4. By Distribution Channel
9.5. South Africa Topical Pain Relief Market Outlook, 2016-2026F
9.5.1. Market Size & Analysis
9.5.1.1. Market Revenues
9.5.2. Market Share & Analysis
9.5.2.1. By Type
9.5.2.2. By Therapeutic Class
9.5.2.3. By Formulation
9.5.2.4. By Distribution Channel
9.6. Turkey Topical Pain Relief Market Outlook, 2016-2026F
9.6.1. Market Size & Analysis
9.6.1.1. Market Revenues
9.6.2. Market Share & Analysis
9.6.2.1. Type
9.6.2.2. By Therapeutic Class
9.6.2.3. By Formulation
9.6.2.4. By Distribution Channel
10. Asia-Pacific Topical Pain Relief Market Outlook, 2016-2026F
10.1. Market Size & Analysis
10.1.1. Market Revenues
10.2. Market Share & Analysis
10.2.1. By Type
10.2.2. By Therapeutic Class
10.2.3. By Formulation
10.2.4. By Distribution Channel
10.2.5. By Country
10.2.5.1. China
10.2.5.2. India
10.2.5.3. Japan
10.2.5.4. South Korea
10.2.5.5. Australia
10.2.5.6. New Zealand
10.2.5.7. Others
10.3. China Topical Pain Relief Market Outlook, 2016-2026F
10.3.1. Market Size & Analysis
10.3.1.1. Market Revenues
10.3.2. Market Share & Analysis
10.3.2.1. Type
10.3.2.2. By Therapeutic Class
10.3.2.3. By Formulation
10.3.2.4. By Distribution Channel
10.4. India Topical Pain Relief Market Outlook, 2016-2026F
10.4.1. Market Size & Analysis
10.4.1.1. Market Revenues
10.4.2. Market Share & Analysis
10.4.2.1. Type
10.4.2.2. By Therapeutic Class
10.4.2.3. By Formulation
10.4.2.4. By Distribution Channel
10.5. Japan Topical Pain Relief Market Outlook, 2016-2026F
10.5.1. Market Size & Analysis
10.5.1.1. Market Revenues
10.5.2. Market Share & Analysis
10.5.2.1. Type
10.5.2.2. By Therapeutic Class
10.5.2.3. By Formulation
10.5.2.4. By Distribution Channel
10.6. South Korea Topical Pain Relief Market Outlook, 2016-2026F
10.6.1. Market Size & Analysis
10.6.1.1. Market Revenues
10.6.2. Market Share & Analysis
10.6.2.1. Type
10.6.2.2. By Therapeutic Class
10.6.2.3. By Formulation
10.6.2.4. By Distribution Channel
10.7. Australia Topical Pain Relief Market Outlook, 2016-2026F
10.7.1. Market Size & Analysis
10.7.1.1. Market Revenues
10.7.2. Market Share & Analysis
10.7.2.1. Type
10.7.2.2. By Therapeutic Class
10.7.2.3. By Formulation
10.7.2.4. By Distribution Channel
10.8. New Zealand Topical Pain Relief Market Outlook, 2016-2026F
10.8.1. Market Size & Analysis
10.8.1.1. Market Revenues
10.8.2. Market Share & Analysis
10.8.2.1. Type
10.8.2.2. By Therapeutic Class
10.8.2.3. By Formulation
10.8.2.4. By Distribution Channel
11. Global Topical Pain Relief Market Government Regulations and Policies
12. Global Topical Pain Relief Market Trends & Insights

13. Global Topical Pain Relief Market Dynamics
13.1. Growth Drivers
13.2. Challenges
13.3. Impact Analysis

14. Global Topical Pain Relief Market Hotspot & Opportunities

15. Global Topical Pain Relief Market Key Strategic Imperatives for Success & Growth

16. Competition Outlook
16.1. Competition Matrix
16.1.1. Target Markets
16.1.2. Research & Development
16.1.3. Collaborations & Strategic Alliances
16.1.4. Key Business Expansion Initiatives
16.1.5. Business Restructuring- Mergers, Acquisitions, JVs
16.1.6. Strategic Initiatives
16.2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
16.2.1. AdvaCare Pharma
16.2.2. GlaxoSmithKline plc.
16.2.3. Sanofi
16.2.4. Johnson & Johnson
16.2.5. Novartis AG
16.2.6. Reckitt Benckiser Group plc
16.2.7. Sun Pharmaceutical Industries Ltd.
16.2.8. Pfizer Inc.
16.2.9. Topical BioMedics, Inc. (Topricin)
16.2.10. Exzell Pharma
16.2.11. Emami Group

17. Disclaimer